![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0025.png)
25
7.
Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto
B, Graus F, et al. Revised diagnostic criteria for
neuromyelitis optica (NMO).Application in a
series of suspected patients. J Neurol
2007;254:1233-7.
9.
Fazio R, Malosio ML, Lampasona V, De Feo D,
Privitera D, Marnetto F, et al. Antiacquaporin 4
antibodies detection by different techniques in
neuromyelitis optica patients. Mult Scler
2009;15:1153-63.
10.
Jarius S, Aboul-Enein F, Waters P, Kuenz B,
Hauser A, Berger T, et al. Antibody to
aquaporin-4 in the long-term course of
neuromyelitis optica. Brain 2008;131(Pt 11):3072-
80.
11.
Balcer LJ, Galetta SL. Treatment of acute
demyelinating optic neuritis. Semin Ophthalmol
2002;17:4-10.
12.
Takahashi T, Fujihara K, Nakashima I, Misu T,
Miyazawa I, Nakamura M, et al. Anti-
aquaporin-4 antibody is involved in the
pathogenesis of NMO: a study on antibody titre.
Brain 2007;130(Pt 5):1235-43.
13.
Kapoor R, Miller DH, Jones SJ, Plant GT, Brusa
A, Gass A, et al. Effects of intravenous
methylprednisolone on outcome in MRI-based
prognostic subgroups in acute optic neuritis.
Neurology 1998;50:230-7.